Literature DB >> 30094757

Deletion of the Transcription Factor PGC-1α in Mice Negatively Regulates Bone Mass.

Graziana Colaianni1, Luciana Lippo1,2, Lorenzo Sanesi1, Giacomina Brunetti3, Monica Celi4, Nunzio Cirulli3, Giovanni Passeri5, Janne Reseland6, Ernestina Schipani7, Maria Felicia Faienza8, Umberto Tarantino4, Silvia Colucci3, Maria Grano9.   

Abstract

Peroxisome proliferator-activated receptor-gamma coactivator (PGC1α) is a transcription coactivator that interacts with a broad range of transcription factors involved in several biological responses. Here, we show that PGC1α plays a role in skeletal homeostasis since aged PGC1α-deficient mice (PGC1α-/-) display impaired bone structure. Micro-CT of the tibial mid-shaft showed a marked decrease of cortical thickness in PGC1α-/- (- 11.9%, p < 0.05) mice compared to wild-type littermate. Trabecular bone was also impaired in knock out mice which displayed lower trabecular thickness (Tb.Th) (- 5.9% vs PGC1α+/+, p < 0.05), whereas trabecular number (Tb.N) was higher than wild-type mice (+ 72% vs PGC1α+/+, p < 0.05), thus resulting in increased (+ 31.7% vs PGC1α+/+, p < 0.05) degree of anisotropy (DA), despite unchanged bone volume fraction (BV/TV). Notably, these impairments of cortical and trabecular bone led to a dramatic ~ 48.4% decrease in bending strength (p < 0.01). These changes in PGC1α-/- mice were paralleled by a significant increase in osteoclast number at the cortical bone surface and in serum level of the bone resorption marker, namely, C-terminal cross-linked telopeptides of type I collagen (CTX-I). We also found that in cortical bone, there was lower expression of mRNA codifying for the key bone-building protein Osteocalcin (Ocn). Interestingly, Collagen I mRNA expression was reduced in mesenchymal stem cells from bone marrow of PGC1α-/-, thus indicating that differentiation of osteoblast lineage is downregulated. Overall, results presented herein suggest that PGC1α may play a key role in bone metabolism.

Entities:  

Keywords:  Bone; Mitochondria; Osteoblast; Osteocalcin; Osteoclast; Peroxisome proliferator-activated receptor-gamma coactivator

Mesh:

Substances:

Year:  2018        PMID: 30094757     DOI: 10.1007/s00223-018-0459-4

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  6 in total

1.  The tethering function of mitofusin2 controls osteoclast differentiation by modulating the Ca2+-NFATc1 axis.

Authors:  Anna Ballard; Rong Zeng; Allahdad Zarei; Christine Shao; Linda Cox; Hui Yan; Antonietta Franco; Gerald W Dorn; Roberta Faccio; Deborah J Veis
Journal:  J Biol Chem       Date:  2020-03-12       Impact factor: 5.157

2.  Osteoclast-derived IGF1 is required for pagetic lesion formation in vivo.

Authors:  Kazuaki Miyagawa; Yasuhisa Ohata; Jesus Delgado-Calle; Jumpei Teramachi; Hua Zhou; David D Dempster; Mark A Subler; Jolene J Windle; John M Chirgwin; G David Roodman; Noriyoshi Kurihara
Journal:  JCI Insight       Date:  2020-03-26

3.  Transcriptional regulation of cyclophilin D by BMP/Smad signaling and its role in osteogenic differentiation.

Authors:  Rubens Sautchuk; Brianna H Kalicharan; Katherine Escalera-Rivera; Jennifer H Jonason; George A Porter; Hani A Awad; Roman A Eliseev
Journal:  Elife       Date:  2022-05-30       Impact factor: 8.713

Review 4.  The Novel Role of PGC1α in Bone Metabolism.

Authors:  Cinzia Buccoliero; Manuela Dicarlo; Patrizia Pignataro; Francesco Gaccione; Silvia Colucci; Graziana Colaianni; Maria Grano
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 5.  PGC-1: a key regulator in bone homeostasis.

Authors:  Haoling Chen; Wenguo Fan; Hongwen He; Fang Huang
Journal:  J Bone Miner Metab       Date:  2021-08-23       Impact factor: 2.626

6.  Effects of mild hyperbaric oxygen on osteoporosis induced by hindlimb unloading in rats.

Authors:  Ai Takemura; Paola Divieti Pajevic; Tatsuro Egawa; Rika Teshigawara; Tatsuya Hayashi; Akihiko Ishihara
Journal:  J Bone Miner Metab       Date:  2020-04-29       Impact factor: 2.626

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.